Health
Australian-led international study: Full-dose blood thinners benefit moderately ill COVID-19 patients – Monash University
Full-dose anticoagulation with the blood thinner heparin improves survival outcomes and reduces the need for vital organ support…
05 August 2021
Full-dose anticoagulation with the blood thinner heparin improves survival outcomes and reduces the need for vital organ support such as mechanical ventilation in moderately ill COVID-19 patients, but does not yield the same positive outcomes…
Continue Reading
